Discover more:
- 1318 beds
- 59 clinical units
- Over 2000 scientists in around 100 research groups
- 4 research divisions
- 4 research institutes
- 4 technological research centers
- 8 clinical research centers
- 812 patents in 130 patent families in these areas:
gene and cell therapy, regenerative medicine, immunology, transplantation, infectious diseases, neruscoeinces and oncology. - 5 spin offs: Genenta, Genespire, Biorek, Epsilen Bio (now part of Chroma Medicine) and Repron Therapeutics
- Relevant industrial collaborations: AstraZeneca, Orchard Therapeutics, Intellia, SmartImmune, Amgen, Dompè, Kite, Tes Pharma, Menarimi silicon Bioystem, Miltenyi BIotec
